Chairman at Idorsia (SWX: IDIA.SW), former EVP, COO and board director of Cellectis (NASDAQ: CLLS). Prior to that, Head of Global Pharmaceutical Operations at Pierre Fabre and in senior corporate and regional roles at Wyeth (US and Europe). Medical Doctor.
Current role